Personalized prediction model for miscarriage: in-depth sperm DNA fragmentation
Journal of Assisted Reproduction and Genetics · 2025
DOI: 10.1007/s10815-025-03445-1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Assisted Reproduction and Genetics, 2025. Verfasst von Chun-I Lee und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infertility Clinic, Taiwan, IVF Centers Lee Women'S Hospital, Taichung, Taiwan. Hauptthemen laut MEDLINE: DNA Fragmentation, Abortion, Spontaneous, Spermatozoa. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
PURPOSE: We investigated how different types of sperm DNA fragmentation (SDF) in males, in conjunction with varying levels of female reproductive potential, jointly impact ICSI outcomes. METHODS: We retrospectively analyzed 195 couples undergoing ICSI, categorizing them by normal or poor prognosis according to POSEIDON criteria. Female factors included age, anti-Müllerian hormone (AMH), and oocyte retrieval numbers. Male factors included semen parameters, total SDF, and specific double-strand breaks (DSBs). Reproductive outcomes were followed up at different gestational stages, including clinical pregnancy, early gestation failure, live birth, and miscarriage. Risk factors were identified using univariate and multivariable logistic regression, and their predictive power was assessed via the receiver operating characteristic (ROC) curve. RESULTS: In the normal group, female factors were primarily associated with reproductive failures. Non-pregnancy cases had lower AMH (4 ng/mL vs. 3.2 ng/mL), and miscarriage cases had fewer oocytes retrieved (15 vs. 10.5). However, the risk factor profile was distinct in poor prognosis. Male factors, including reduced sperm motility (68% vs. 54.5%), lower normal sperm morphology (5.5% vs. 2.5%), and elevated DSBs (7.5% vs. 18.8%) were linked to miscarriage. DSBs presented as the independent predictor of miscarriage risk (odds ratio: 1.19, 95% CI: 1.04-1.36), with a DSB cutoff of 19% providing 81% accuracy in predicting miscarriage. CONCLUSION: Paternal effect is pronounced in women with poor prognosis, where elevated DSBs are linked to an increased risk of miscarriage. We propose a refined pipeline in which DSB testing is considered as initial evaluation before assisted reproductive treatments, especially for infertile couples with poor prognosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Infertility Clinic, Taiwan, IVF Centers Lee Women'S Hospital, Taichung, Taiwan.
- Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan.
- Department of Obstetrics and Gynecology, Chung Shan Medical University, Taichung, Taiwan.
- Department of Post-Baccalaureate Medicine, National Chung Hsing University, Taichung, Taiwan.
- Department of Obstetrics and Gynecology, University of Texas Health Science Center, San Antonio, TX, USA.
- Division of Infertility Clinic, Taiwan, IVF Centers Lee Women'S Hospital, Taichung, Taiwan. msleephd@gmail.com.
Zitieren
APA
Lee, C. I., Wang, T. E., Chen, C. H., Huang, C. C., Tsao, H. M., Lee, T. H., Chang, T. A., Hsu, C. T., & Lee, M. S. (2025). Personalized prediction model for miscarriage: in-depth sperm DNA fragmentation. Journal of Assisted Reproduction and Genetics. https://doi.org/10.1007/s10815-025-03445-1
Vancouver
Lee CI, Wang TE, Chen CH, Huang CC, Tsao HM, Lee TH, et al. Personalized prediction model for miscarriage: in-depth sperm DNA fragmentation. Journal of Assisted Reproduction and Genetics. 2025. doi:10.1007/s10815-025-03445-1
BibTeX
@article{Lee2025,
author = {Lee, Chun-I and Wang, Tse-En and Chen, Chien-Hong and Huang, Chun-Chia and Tsao, Hui-Mei and Lee, Tsung-Hsien and Chang, Tiencheng Arthur and Hsu, Cheng-Teng and Lee, Maw-Sheng},
title = {Personalized prediction model for miscarriage: in-depth sperm DNA fragmentation},
journal = {Journal of Assisted Reproduction and Genetics},
year = {2025},
doi = {10.1007/s10815-025-03445-1}
}
EUVIMED